BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24113876)

  • 1. Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures.
    Lee JY; Lee DH; Kim HA; Choi SA; Lee HJ; Park CK; Phi JH; Wang KC; Kim SU; Kim SK
    J Neurooncol; 2014 Jan; 116(1):49-57. PubMed ID: 24113876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
    Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
    Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
    Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
    Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
    Park GT; Kim SU; Choi KC
    Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
    Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
    Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.
    Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH
    Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
    Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.
    Ahmed AU; Thaci B; Tobias AL; Auffinger B; Zhang L; Cheng Y; Kim CK; Yunis C; Han Y; Alexiades NG; Fan X; Aboody KS; Lesniak MS
    J Natl Cancer Inst; 2013 Jul; 105(13):968-77. PubMed ID: 23821758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
    Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
    Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth of K562 human leukemia cells was inhibited by therapeutic neural stem cells in cellular and xenograft mouse models.
    Park GT; Heo JR; Kim SU; Choi KC
    Cytotherapy; 2018 Sep; 20(9):1191-1201. PubMed ID: 30078654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.
    Yi BR; Park MA; Lee HR; Kang NH; Choi KJ; Kim SU; Choi KC
    Mol Oncol; 2013 Jun; 7(3):543-54. PubMed ID: 23403306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact and encirclement of glioma cells in vitro is an intrinsic behavior of a clonal human neural stem cell line.
    Khosh N; Brown CE; Aboody KS; Barish ME
    PLoS One; 2012; 7(12):e51859. PubMed ID: 23240066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
    Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
    Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
    Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
    Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithyroid cancer effects of human neural stem cells expressing therapeutic genes on anaplastic thyroid cancer cells.
    Shin HJ; Hwang KA; Go RE; Kim SU; Choi KC
    J Cell Biochem; 2020 Feb; 121(2):1586-1598. PubMed ID: 31512776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor therapeutic effects of cytosine deaminase and interferon-β against endometrial cancer cells using genetically engineered stem cells in vitro.
    Yi BR; Kang NH; Hwang KA; Kim SU; Jeung EB; Choi KC
    Anticancer Res; 2011 Sep; 31(9):2853-61. PubMed ID: 21868529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective delivery of a therapeutic gene for treatment of head and neck squamous cell carcinoma using human neural stem cells.
    Kwon SK; Kim SU; Song JJ; Cho CG; Park SW
    Clin Exp Otorhinolaryngol; 2013 Sep; 6(3):176-83. PubMed ID: 24069522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase.
    Lim SH; Choi SA; Lee JY; Wang KC; Phi JH; Lee DH; Song SH; Song JH; Jin X; Kim H; Lee HJ; Lim I; Kim SU; Kim SK
    Cancer Gene Ther; 2011 Nov; 18(11):817-24. PubMed ID: 21869821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth.
    Kim KY; Kim SU; Leung PC; Jeung EB; Choi KC
    Cancer Sci; 2010 Apr; 101(4):955-62. PubMed ID: 20704576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma.
    Tobias AL; Thaci B; Auffinger B; Rincón E; Balyasnikova IV; Kim CK; Han Y; Zhang L; Aboody KS; Ahmed AU; Lesniak MS
    Stem Cells Transl Med; 2013 Sep; 2(9):655-66. PubMed ID: 23926209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.